The Architect Of Biogen's Controversial Alzheimer's Strategy, Al Sandrock, To Retire

 
• By Jessica Merrill and Alaric DeArment
Biogen
Biogen's Al Sandrock is retiring • Source: Alamy

More from Leadership

More from Scrip